Response to comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: The Hong Kong diabetes registry. Diabetes;59:1254-1260

Diabetes

Volumn 59, Issue 9, 2010, Pages

  Yang, Xilin ^a   Ma, Ronald C W ^a   Chan, Juliana C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

CANCER INCIDENCE; CANCER RISK; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; FOLLOW UP; HEART PROTECTION; HONG KONG; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; KAPLAN MEIER METHOD; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REGISTER; SENSITIVITY ANALYSIS; SMOKING HABIT;

EID: 77956376892     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db10-0859     Document Type: Letter

References (6)

1. Carstensen B. Comment on: Yang et al. (2010) Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry (Letter). Diabetes 2010;59:e17. DOI: 10.2337/db10-0777
2. Yang X, Ko GTC, So WY, Ma RCW, Yu LWL, Kong APS, Zhao H, Chow C-C, Tong PCY, Chan JCN. Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes 2010;59:1254-1260
3. Johnson JA, Gale EAM. Diabetes, insulin use, and cancer risk: are observational studies part of the solution - or part of the problem? Diabetes 2010;59:1129-1131
4. Bowker SL, Yasui Y, Veugelers P, Johnson JA. Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of timevarying exposure. Diabetologia 2010;53:1631-1637
5. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003;158:915-920 (Pubitemid 37323253)
6. Gerstein HC. Does insulin therapy promote, reduce, or have a neutral effect on cancers? JAMA 2010;303:446-447